Further analysis of chemokine receptor expression on T-cells revealed that the percentages of CCR4+ and CCR5+ cells within the CD4+ subset were greater in AD, albeit only just achieving significance (Figure 5A, B), whereas the difference in CCR6 expression was highly significant (Figure 5C). This evidence concerns the gene CCR6 and Alzheimer disease.